The EP300 gene helps control when other genes turn on, which supports growth, brain development, and DNA repair. If it does not work properly, the body may have trouble following normal development patterns. Pathogenic variants in the EP300 gene can cause Rubinstein-Taybi syndrome type 2, which may involve developmental delay, learning difficulties, short stature, and changes in the face, hands, or feet. Variants in this gene are also found in some cancers, where they can affect how cells grow.
What is a gene?
Genes are stretches of DNA that carry instructions cells use to make molecules or regulate activities in the body. Some provide the code for proteins, which are the parts of cells that do the work. Others mainly guide when certain processes happen, where they take place, and how active they are. In combination, genes affect how the body grows and works, and they can influence your response to food, stress, or medicines. More detail on this topic is available in the LearnHub.
Overview
EP300Gene function
What if the gene works
The EP300 gene helps switch many other genes on and off at the right time. This supports normal growth, early development, and DNA repair.
Risk
What if the gene does not work
Variants in the EP300 gene can cause Rubinstein-Taybi syndrome type 2, with developmental delay, learning difficulties, and growth or facial features. Variant severity can change timing and how strong features are; some acquired EP300 variants are linked to cancer.
Treatment
What does that mean for your treatment
No EP300-specific treatment or drug choice is currently established for pathogenic or loss-of-function variants in the EP300 gene. In cancer research, the EP300 gene is being studied as a biomarker and possible drug target, but this has not led to routine treatment decisions.
Conditions associated with EP300
Gene function
What if the gene works
Your cells use the EP300 gene to help turn the right genes on at the right time. It supports everyday cell activity by making DNA easier to access and by helping control proteins pass along their signals. Understanding what the EP300 gene does in your cells helps explain how many normal cell programs stay in balance.
The EP300 gene helps cells switch many genes on when they are needed. Its protein acts like a bridge, linking control proteins with the cell machinery that reads DNA.
The protein from the EP300 gene adds small chemical tags called acetyl groups to histones (DNA packing proteins). This loosens tightly packed DNA so important instructions are easier for cells to read.
By controlling when groups of genes are active, the EP300 gene supports normal cell growth and cell specialization. This helps developing and mature tissues follow the right instructions for their everyday work.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These changes are common and help explain normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can more significantly change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the EP300 gene often change the p300 protein so it is shorter, less stable, or less able to add small chemical tags that help control when other genes turn on. This is the main way how EP300 gene variants affect protein function in cells. Some variants only partly reduce activity, while more severe variants can leave little or no working protein, which may lead to earlier or more noticeable features in conditions linked to the EP300 gene.
How variants are linked to conditions
Pathogenic variants in the EP300 gene can cause Rubinstein-Taybi syndrome type 2, a condition linked with developmental delay, learning difficulties, distinctive facial features, and broad thumbs or big toes. Some specific EP300 gene variants are also linked to Menke-Hennekam syndrome 2, which can affect growth, feeding, behavior, and development. This is the main pattern behind EP300 gene variants linked to conditions described in medical genetics.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or reduce health risks related to the EP300 gene. Most harmful EP300 changes happen for the first time in a child, but if a parent carries the same change, the chance of passing it on is higher.
Inheritance of EP300 variants
For families asking how EP300 gene variants are inherited, the best established pattern is autosomal dominant. This means a person with a disease causing variant in one copy of the EP300 gene can pass it to each child with a 50% chance in each pregnancy. EP300 related Rubinstein-Taybi syndrome type 2 often happens because of a new, de novo variant, so the child is the first person in the family to have it. When a parent carries the variant, it can be passed to sons or daughters equally.
What does my EP300 result mean for my family?
For EP300, the main family pattern is dominant, so a parent with the same disease-causing change can pass it to each child with a 1 in 2 chance. Close relatives, especially parents, brothers, sisters, and children, may want to discuss whether the same result could be present in the family. Some EP300 changes happen for the first time in one person, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
To find variants in the EP300 gene, genetic testing reads DNA from blood, saliva, or a cheek swab and compares the gene with the usual sequence, showing how to find out about variants and what genetic testing is and how it works.
When should I consider getting a genetic test?
Testing for changes in the EP300 gene may be worth discussing if a child or adult has signs of Rubinstein-Taybi syndrome, a condition linked with developmental delay, learning difficulties, short stature, and unusually broad thumbs or big toes. It can also help when this condition is known or strongly suspected in the family.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and on the kind of variant involved. Over time, how the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get the expected benefit while the other may notice less effect or be more sensitive to side effects, partly because their bodies break down or handle the drug differently. These differences are common and can influence how strongly a medicine works, how long it stays in the body, or how likely side effects are.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It looks at gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes help shape both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the EP300 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. Questions about side effects, new medicines, or changes in treatment are best discussed with your doctor.
History
Researchers first identified the EP300 gene in the late 1980s while studying how adenovirus proteins interact with human cells, and it was named for the protein p300. Soon after, scientists recognized EP300 as closely related to another important gene, CBP, which helped place it at the center of early work on gene regulation. From these first observations, research expanded steadily. In the 1990s and 2000s, EP300 became increasingly important in cancer research as studies linked changes in this gene to several tumor types. Later, rare inherited variants in the EP300 gene were also connected with Rubinstein-Taybi syndrome, which broadened medical interest beyond cancer biology. This history made EP300 part of a wider shift toward understanding how genes can influence health by altering the way other genes are switched on and off.